SeekingAlpha · Aug 13, 2026
Tenon Medical, Inc. (TNON) Q2 2026 Earnings Call Transcript
Tenon Medical, Inc. (TNON) Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsSteven Foster - CEO, President & DirectorKevin...
NASDAQ · TNON
Tenon Medical, Inc.
Healthcare · Medical - Devices
$5.96
Down-$0.80 (-13.42%)
Updated Aug 14, 2026, 11:06 PM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.87M
- P/E ratio
- -0.74
- Dividend yield
- 0.00%
- 52-week range
- $0.18 – $7.70
- Volume
- 74.63K
- Avg. volume
- 419.87K
Price performance
TNON price history
1M range · 0 trading sessions · Daily adjusted prices
TNON does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest TNON news
The latest Smart Investors Daily articles mentioning TNON.
Stock researchCompany · Overview
TNON research
Overview
Company profile and research snapshot.
Company profile
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 9, 2025 | Alliance Global Partners | Buy | — |
| Nov 15, 2024 | Maxim Group | Buy | — |
| Aug 14, 2024 | Benchmark | Speculative Buy | — |
| Apr 15, 2024 | Benchmark | Speculative Buy | — |
| Mar 10, 2023 | Benchmark | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 11, 2026
Tenon Medical Files Shelf Registration To Offer Securities Up To $100M
-SEC Filing
Benzinga · Jul 20, 2026
Tenon Medical Regains Nasdaq Compliance Relating To Maintaining Shareholders' Equity Minimum Of $2.5M
On July 17, 2026, the Company received a notice from Nasdaq that, based on the July 10 8-K (as defined below), the Company had regained compliance with the Stockholders' Equity Rule (as defined below). However, if
Benzinga · Jul 2, 2026
Tenon Medical Gets FDA Clearance For Its Catamaran SI Joint Fusion System,
Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
